Adverse drug reaction of the month
Acute hepatocellular and cholestatic injury in a patient taking
celecoxib
S Nachimuthua, L Volfinzona, L Gopalb
a Department of
Internal Medicine, Lutheran Medical Center, State University of New
York Health Science Center, Brooklyn, NY 11220, USA, b Department of
Internal Medicine, Brookdale University Hospital and Medical Center,
Brooklyn, NY
Correspondence to: Dr Nachimuthu nsen1{at}hotmail.com
Submitted 5 November
1999;
Accepted 27 April 2000
A case of acute hepatocellular and cholestatic liver injury
that may have been associated with the use of celecoxib is described. This case was reported to US Food and Drug Administration and the
manufacturer of celecoxib.
Keywords: celecoxib; COX-2 inhibitors; acute hepatic injury; adverse effects
© 2001 by The Fellowship of Postgraduate Medicine
This article has been cited by other articles:
-
Johnson, K. K, Green, D. L, Rife, J. P, Limon, L.
(2005). Sulfonamide Cross-Reactivity: Fact or Fiction?. The Annals of Pharmacotherapy
39: 290-301
[Abstract] [Full Text] -
O'connor, N., Dargan, P.I., Jones, A.L.
(2003). Hepatocellular damage from non-steroidal anti-inflammatory drugs. QJM
96: 787-791
[Abstract] [Full Text] -
Mohammed, F., Smith, A. D, O'Beirne, J. P, Cairns, S.
(2002). Cholestatic hepatitis in association with celecoxib. BMJ
325: 220-220
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
